IBIO

NASDAQStock

iBio, Inc.

$2.46-0.03 (-1.40%)

52-Week Range

$0.57

$5.08

Key Stats

Market Cap

38.8M

P/E Ratio

—

Dividend Yield

—

Beta

1.23

Volume

940.8K

Avg Volume

1.1M

Performance

+18.01%

+36.07%

+178.34%

YTD

+23.27%

-50.98%

-93.87%

-99.73%

Price Chart

ETF Exposure

IBIO is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
STSB	iShares Factors US Small Blend Style ETF	0.03%	1,799	$2K	$7.3M	0.35%
VXF	Vanguard Extended Market ETF	0.00%	235,369	$494K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	33	$93	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,179	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	5	$16	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	671,500	$1.4M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,531	$10K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	304	$866	$1.29B	0.17%

About IBIO ETF Exposure

iBio, Inc. (IBIO) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 38.8M, IBIO is a widely held institutional stock. The stock currently trades at $2.46. Investors can gain exposure to IBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IBIO, sorted by portfolio weight.